Skip to main content

Table 3 The half-maximal cell growth inhibitory concentrations (GI50) and mass spectra data of compounds 117. All HR/MS data were collected in [M + H]+ mode

From: Design, synthesis, and biological evaluation of chalcones for anticancer properties targeting glycogen synthase kinase 3 beta

Compound

Mass (M + H), (calcd./found)

GI50, (μM)

1

317.0177/317.0179

21.46 ± 0.17

2

253.1229/253.1230

29.59 ± 0.84

3

273.0682/273.0692

13.35 ± 0.03

4

289.1229/289.1167

172.20 ± 2.27

5

289.1229/289.1232

15.67 ± 0.02

6

303.0788/303.0811

9.49 ± 0.02

7

329.1389/329.1379

12.34 ± 0.01

8

314.1028/314.1006

4.96 ± 0.03

9

347.0283/347.0299

8.89 ± 0.09

10

283.1334/283.1350

19.49 ± 0.09

11

273.0682/273.0688

14.20 ± 0.10

12

287.1083/287.1069

7.89 ± 0.02

13

253.1229/253.1214

4.51 ± 0.02

14

284.0923/284.0902

1.33 ± 0.02

15

319.1334/319.1356

13.50 ± 0.02

16

319.1334/319.1356

10.93 ± 0.06

17

299.1283/299.1270

9.66 ± 0.06